World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
123
Citations
57140
World Ranking
307
National Ranking
194

Medicine

D-Index
123
Citations
57323
World Ranking
3347
National Ranking
1840

Howard E. Gendelman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Howard E. Gendelman sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 646 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Howard E. Gendelman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Howard E. Gendelman sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 123 D-Index — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Howard E. Gendelman is affiliated with the University of Nebraska Medical Center in the United States. Their research spans multiple areas within medicine and neuroscience, particularly focusing on infectious diseases, molecular biology, and virology. The scientist has contributed significantly to fields such as neurology, infectious diseases, and epidemiology.

Their recent publications include the following papers:

  • Diagnostics for SARS-CoV-2 infections, 2021, Nature Materials
  • The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections, 2020, Journal of Neuroimmune Pharmacology
  • The 2022 outbreak and the pathobiology of the monkeypox virus, 2022, Journal of Autoimmunity
  • Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons, 2020, Brain
  • Proteomic and biological profiling of extracellular vesicles from Alzheimer's disease human brain tissues, 2020, Alzheimer's & Dementia

The scientist's research topics cover a broad range of areas, including:

  • Neuroinflammation and Neurodegeneration Mechanisms
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • Parkinson's Disease Mechanisms and Treatments
  • Alzheimer's disease research and treatments
  • COVID-19 Clinical Research Studies
  • CRISPR and Genetic Engineering

Frequent co-authors collaborating with this scientist include:

  • R. Lee Mosley
  • Benson Edagwa
  • Bhavesh D. Kevadiya
  • Jatin Machhi
  • Santhi Gorantla

Their publications are often found in journals and venues such as:

  • NeuroImmune Pharmacology and Therapeutics
  • Journal of Neuroimmune Pharmacology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • UNC Libraries

Howard E. Gendelman's work emphasizes overlapping domains in neuroscience and infectious diseases, addressing clinical and molecular mechanisms through diverse methodologies. The research covers neurodegenerative diseases like Alzheimer's and Parkinson's disease as well as infectious agents including HIV and SARS-CoV-2, reflecting a multidisciplinary approach within medicine and biology.

Best Publications

  • Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

    Akio Adachi;Howard E. Gendelman;Scott Koenig;Thomas Folks

  • Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy.

    Scott Koenig;Howard E. Gendelman;Jan M. Orenstein;Mauro Carlo Dal Canto

  • The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells

    Nina K. Heinzinger;Michael I. Bukrinsky;Sheryl A. Haggerty;Anna M. Ragland

  • A call for transparent reporting to optimize the predictive value of preclinical research

    Story C. Landis;Susan G. Amara;Khusru Asadullah;Chris P. Austin

  • Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes

    H E Gendelman;J M Orenstein;M A Martin;C Ferrua

  • Diagnostics for SARS-CoV-2 infections.

    Bhavesh D. Kevadiya;Jatin Machhi;Jonathan Herskovitz;Maxim D. Oleynikov

  • Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome.

    Stuart A. Lipton;Howard E. Gendelman

  • The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections.

    Jatin Machhi;Jonathan Herskovitz;Ahmed M. Senan;Debashis Dutta

  • Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease.

    Peter Genis;Marti Jett;Edward W. Bernton;Thomas Boyle

  • Oxidative stress and the pathogenesis of neurodegenerative disorders.

    Ashley Reynolds;Chad Laurie;R. Lee Mosley;Howard E. Gendelman

  • Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease

    Anamitra Ghosh;Avik Roy;Xiaojuan Liu;Jeffrey H. Kordower

  • Biological and biochemical characterization of a cloned leu-3− cell surviving infection with the acquired immune deficiency syndrome retrovirus

    T. M. Folks;D. Powell;M. Lightfoote;S. Koenig

  • Nanotechnology: A Focus on Nanoparticles as a Drug Delivery System

    Jeffrey D. Kingsley;Huanyu Dou;Justin Morehead;Barrett Rabinow

  • Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses.

    Howard E. Gendelman;William Phelps;Lionel Feigenbaum;Jeffrey M. Ostrove

  • Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson’s disease

    R Lee Mosley;Eric J. Benner;Irena Kadiu;Mark Thomas

  • Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms.

    Leon G. Epstein;Howard E. Gendelman

  • Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease.

    Ashley D. Reynolds;Rebecca Banerjee;Jianou Liu;Howard E. Gendelman

  • The macrophage in the persistence and pathogenesis of HIV infection

    H. E. Gendelman;J. M. Orenstein;L. M. Baca;Barbara Weiser

  • Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease

    Ashley D. Reynolds;David K. Stone;Jessica A.L. Hutter;Eric J. Benner

  • Interferon-γ and Tumor Necrosis Factor-α Regulate Amyloid-β Plaque Deposition and β-Secretase Expression in Swedish Mutant APP Transgenic Mice

    Masaru Yamamoto;Tomomi Kiyota;Masahide Horiba;James L. Buescher

Frequent Co-Authors

Larisa Y. Poluektova
Larisa Y. Poluektova University of Nebraska Medical Center
Stuart A. Lipton
Stuart A. Lipton Scripps Research Institute
Alexander V. Kabanov
Alexander V. Kabanov University of North Carolina at Chapel Hill
Yuri Persidsky
Yuri Persidsky Temple University
Igor Grant
Igor Grant University of California, San Diego
Harris A. Gelbard
Harris A. Gelbard University of Rochester Medical Center
Monte S. Meltzer
Monte S. Meltzer Walter Reed Army Institute of Research
Jialin C. Zheng
Jialin C. Zheng Tongji University
Tsuneya Ikezu
Tsuneya Ikezu Boston University
Howard S. Fox
Howard S. Fox University of Nebraska Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often leads students to explore related healthcare fields that enhance patient care and research opportunities. For those interested in clinical roles, understanding nursing pathways is valuable. For example, some students may start with an Licensed Practical Nurse (LPN) certification and seek the which lpn programs are easiest to get into, balancing accessibility and quality education.

The natural next step might be advancing to a Nurse Practitioner degree. Identifying programs that suit individual needs is crucial, and exploring the easiest nurse practitioner program options can help streamline this transition.

For those focused on mental health within Immunology or broader healthcare, psychiatric nurse practitioner programs offer a specialized pathway. Online learning options provide flexibility, with guides highlighting the best pmhnp programs online that combine quality instruction with excellent clinical placements.

Cost considerations are equally important. Prospective students can find the cheapest pmhnp programs online to reduce financial burden without sacrificing education standards. These pathways enrich Immunology careers by providing diverse skill sets and better patient outcomes.

Best Scientists Citing Howard E. Gendelman

Trending Scientists

Recently Published Articles